AzurRx BioPharma jumps 18% over formulation trial for treatment of COVID-19-associated gastrointestinal infections
February 09 2021 - 9:02AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
AzurRx BioPharma (NASDAQ:AZRX)
Historical Stock Chart
From Aug 2024 to Sep 2024
AzurRx BioPharma (NASDAQ:AZRX)
Historical Stock Chart
From Sep 2023 to Sep 2024